日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Four-Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI-52

TASUKI-52研究中，纳武利尤单抗联合化疗和贝伐单抗治疗非鳞状非小细胞肺癌患者的四年疗效

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70330
Lee, Jong-Seok; Sugawara, Shunichi; Kang, Jin-Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Lee, Ki Hyeong; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Goto, Yasushi; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru; Nakagawa, Kazuhiko
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Plain language summary of TASUKI-52: A study looking at nivolumab plus platinum chemotherapy and bevacizumab as a combined treatment for people with advanced or recurrent nonsquamous non-small cell lung cancer (NSCLC)

TASUKI-52 简明语言摘要：一项研究，旨在探讨纳武利尤单抗联合铂类化疗和贝伐单抗作为治疗晚期或复发性非鳞状非小细胞肺癌 (NSCLC) 患者的联合疗法。

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2617855
Sugawara, Shunichi; Lee, Jong-Seok; Kang, Jin-Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Lee, Ki Hyeong; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Goto, Yasushi; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru; Nakagawa, Kazuhiko
肺癌
肿瘤
肿瘤免疫
CLC
细胞生物学
发表日期：2026
文献求助 收藏

Single-cell multi-omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK-positive lung cancer

单细胞多组学揭示ALK阳性肺癌免疫治疗反应不良的肿瘤微环境因素

期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.12658
Baek, Seungbyn; Sung, Euijeong; Kim, Gamin; Hong, Min Hee; Lee, Chang Young; Shim, Hyo Sup; Park, Seong Yong; Kim, Hye Ryun; Lee, Insuk
肺癌
肿瘤
肿瘤免疫
单细胞
ALK
细胞生物学
肿瘤微环境
免疫/内分泌
发表日期：2025
文献求助 收藏

Comparative single-cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses

对食管癌亚型进行单细胞比较分析，揭示了肿瘤微环境的差异，从而解释了免疫治疗反应的多样性。

期刊:Cancer Communications
影响因子:24.9
doi:10.1002/cac2.70046
Baek, Seungbyn; Cha, Junha; Hong, Min Hee; Kim, Gamin; Koh, Yoon Woo; Kim, Dahee; Son, Wonrak; Ock, Chan-Young; Lee, Seungeun; Hemberg, Martin; Park, Seong Yong; Kim, Hye Ryun; Lee, Insuk
肿瘤
肿瘤免疫
单细胞
食管癌
细胞生物学
肿瘤微环境
免疫/内分泌
发表日期：2025
文献求助 收藏

4-1BB(+) Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy

4-1BB(+)调节性T细胞和抑制性祖细胞耗竭的T细胞赋予抗PD-L1和抗CTLA-4联合疗法耐药性

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2025.102408
Cha, Junha; Kim, Chang Gon; Sim, Nam Suk; Kim, Gamin; Son, Wonrak; Kim, Dahee; Jung, Yurim; Hong, Hyun Jun; Lee, Hae Been; Kim, Jaehyung; Kim, Jinna; Yoon, Sun Och; Go, Seokhyeong; Kim, Jeongah; Seong, Euijung; Baek, Seungbyn; Kim, Kyung Hwan; Hong, Min Hee; Koh, Yoon Woo; Lee, Insuk; Kim, Hye Ryun
T细胞
PD-L1
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma.

异体自然杀伤细胞联合西妥昔单抗治疗头颈部鳞状细胞癌的抗肿瘤疗效的临床前研究

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-03959-8
Kim Chaeyeon, Han Mina, Kim Gamin, Son Wonrak, Kim Jeongah, Gil Minchan, Rhee Yong-Hee, Sim Nam Suk, Kim Chang Gon, Kim Hye Ryun
肿瘤
发表日期：2025
文献求助 收藏

Optimizing management of stage IV EGFR mutant non-small cell lung cancer in Asia: An expert opinion

亚洲地区IV期EGFR突变型非小细胞肺癌管理优化：专家意见

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.35512
Chang, Gee-Chen; Kapoor, Akhil; Lee, Chee Khoon; Su, Chunxia; Chan, Daniel; Ladrera, Guia Elena Imelda; Kim, Hye Ryun; Sumon, Mostafa Aziz; Suryavanshi, Moushumi; Andarini, Sita; Yoshida, Tatsuya; Reungwetwattana, Thanyanan; Nguyen, Tuan Khoi; Voon, Pei Jye
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum

基于常规临床、实验室和病理参数的真实世界疗效和生物标志物分析：一线抗PD-1联合氟尿嘧啶和铂类药物治疗转移性或不可切除食管癌的疗效及生物标志物分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17193149
Jeong, Jiyun; Seo, Seyoung; Kim, Sung-Bae; Song, Joon Seon; Kim, Hye Ryun; Cho, Byoung Chul; Jung, Minkyu; Kim, Chang Gon; Hong, Moonki; Hong, Min Hee; Park, Sook Ryun
食管癌
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial

Alpelisib 治疗头颈部鳞状细胞癌的疗效因 PIK3CA 突变位点而异：来自 KCSG HN 15-16 TRIUMPH 试验的分析

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2024.1195
Kim, Kyoo Hyun; Hwang, Shinwon; Kim, Min Kyoung; Park, Keon-Uk; Yun, Tak; Lee, Keun-Wook; Kim, Joo Hang; Keam, Bhumsuk; Cho, Byoung Chul; Oh, So Yeon; Cho, Sang Hee; Kim, Sangwoo; Kim, Sung-Bae; Hong, Min Hee; Kim, Hye Ryun
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy

TP53突变对接受靶向治疗或免疫治疗的头颈癌患者的临床影响

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2024.836
Kang, Eun Joo; Hwang, Shinwon; Lee, Yun-Gyoo; Choi, Jong-Kwon; Shin, Seong Hoon; Choi, Yoon Hee; Lee, Keun-Wook; Lee, Hyun Woo; Kim, Min Kyoung; Lim, Seung Taek; Yun, Hwan Jung; Park, Sang-Gon; Kim, Sangwoo; Kim, Sung-Bae; Kim, Hye Ryun
肿瘤
肿瘤免疫
P53
头颈癌
免疫/内分泌
发表日期：2025
文献求助 收藏